Meanwhile, considering a striking regression of TTs with ICB therapy in some ccRCC patients [23–26], we asked whether there was certain subset of CD8+ T cells we recovered may resemble the progenitor exhausted phenotype. This evidence concerns the gene CD8A and nonpapillary renal cell carcinoma.